Accessibility Menu
 

Why Idera Pharmaceuticals Soared 20% in September

Investors sent shares soaring ahead of expected cancer data later this quarter.

By Todd Campbell Updated Oct 6, 2015 at 11:40AM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.